menu
    • menu

    Company profile for Adaptimmune Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Adaptimmune, a leader in T-cell therapy, has clinical trials ongoing for three wholly owned SPEAR T-cells (ADP-A2M4 (MAGE-A4), ADP-A2M10 (MAGE-A10), and ADP-A2AFP (AFP)) in multiple solid tumor indications. The Company's unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T‑cell platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The foundation of our TCR therapies is the ...
    Adaptimmune, a leader in T-cell therapy, has clinical trials ongoing for three wholly owned SPEAR T-cells (ADP-A2M4 (MAGE-A4), ADP-A2M10 (MAGE-A10), and ADP-A2AFP (AFP)) in multiple solid tumor indications. The Company's unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T‑cell platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The foundation of our TCR therapies is the work we did with NY-ESO SPEAR T-cells, which we transitioned to GSK in 2018, showing responses in two solid tumors and treating more than 90 patients in six different indications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Adaptimmune TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    351 Rouse Boulevard Philadelphia, PA 19112
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.adaptimmune.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/adaptimmune/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biotech Sells 4 Cell Therapy Programs for $55M
    Biotech Sells 4 Cell Therapy Programs for $55M

    28 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/adaptimmune-sells-4-cell-therapies-pharma-55m-plans-layoffs

    FIERCE BIOTECH
    28 Jul 2025
    Share Share
    Adaptimmune questions own longevity, axes preclinical funding
    Adaptimmune questions own longevity, axes preclinical funding

    20 Mar 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/adaptimmune-questions-viability-after-bringing-cell-therapy-market-cuts-2-preclinical

    FIERCE BIOTECH
    20 Mar 2025
    Share Share
    AGC Biologics to Support Adaptimmune’s Solid Tumor Cell Therapy
    AGC Biologics to Support Adaptimmune’s Solid Tumor Cell Therapy

    16 Jan 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/agc-biologics-to-support-adaptimmunes-solid-tumor-cell-therapy/

    CONTRACTPHARMA
    16 Jan 2025
    Share Share
    Adaptimmune's cell therapy hits key goal in pivotal sarcoma test
    Adaptimmune's cell therapy hits key goal in pivotal sarcoma test

    13 Nov 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/adaptimmune-gears-another-fda-submission-after-hitting-goal-pivotal-sarcoma-study

    FIERCE BIOTECH
    13 Nov 2024
    Share Share
    First-of-its-kind cell therapy approved by FDA for rare soft tissue cancer
    First-of-its-kind cell therapy approved by FDA for rare soft tissue cancer

    03 Aug 2024

    // PRESS RELEASE

    https://www.adaptimmune.com/investors-and-media/news-center/press-releases/detail/271/adaptimmune-receives-u-s-fda-accelerated-approval-of

    PRESS RELEASE
    03 Aug 2024
    Share Share
    Adaptimmune Gears Up for Potential Approval of First-in-Class Engineered T Cell Therapy
    Adaptimmune Gears Up for Potential Approval of First-in-Class Engineered T Cell Therapy

    29 Jul 2024

    // BIOSPACE

    https://www.biospace.com/drug-development/adaptimmune-gears-up-for-potential-approval-of-first-in-class-engineered-t-cell-therapy

    BIOSPACE
    29 Jul 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search